Skip to content

IRADIMED CORPORATION: 10-Q filed 2014-08-14

What IRADIMED CORPORATION reported in its quarterly report filed 2014-08-14 (fiscal Q2 2014): 44 published measures, 126 facts as tagged in accession 0001104659-14-061045.

This filing

Form
10-Q (quarterly report)
Filed
2014-08-14
Fiscal period
fiscal Q2 2014
Accession
0001104659-14-061045 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IRADIMED CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-06-309,936,606USD
At 2013-12-316,986,871USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-06-302,635,651USD
At 2013-12-311,564,087USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-06-307,300,955USD
At 2013-12-315,422,784USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-06-304,260,988USD
At 2013-12-312,461,559USD
At 2013-06-302,162,594USD
At 2012-12-311,697,306USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,018,821USD91
2014-01-01 to 2014-06-301,542,188USD181
2013-04-01 to 2013-06-30558,309USD91
2013-01-01 to 2013-06-301,202,236USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-06-30218,425USD181
2013-01-01 to 2013-06-3038,187USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-04-01 to 2014-06-304,700,369USD91
2014-01-01 to 2014-06-308,257,606USD181
2013-04-01 to 2013-06-302,775,053USD91
2013-01-01 to 2013-06-305,403,322USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-238,641USD181
2013-01-01 to 2013-06-30-53,842USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-06-304,617,071USD
At 2013-12-313,074,883USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-04-01 to 2014-06-307,000,000shares91
2014-01-01 to 2014-06-307,000,000shares181
2013-04-01 to 2013-06-307,000,000shares91
2013-01-01 to 2013-06-307,000,000shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-04-01 to 2014-06-308,878,170shares91
2014-01-01 to 2014-06-308,868,610shares181
2013-04-01 to 2013-06-308,495,314shares91
2013-01-01 to 2013-06-308,493,897shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-04-01 to 2014-06-300.15USD/shares91
2014-01-01 to 2014-06-300.22USD/shares181
2013-04-01 to 2013-06-300.08USD/shares91
2013-01-01 to 2013-06-300.17USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-04-01 to 2014-06-300.11USD/shares91
2014-01-01 to 2014-06-300.17USD/shares181
2013-04-01 to 2013-06-300.07USD/shares91
2013-01-01 to 2013-06-300.14USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-04-01 to 2014-06-30602,931USD91
2014-01-01 to 2014-06-30907,099USD181
2013-04-01 to 2013-06-30244,129USD91
2013-01-01 to 2013-06-30525,695USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-06-30510,723USD
At 2013-12-31327,343USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-06-30332,282USD181
2013-01-01 to 2013-06-30135,959USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,610,121USD91
2014-01-01 to 2014-06-302,434,204USD181
2013-04-01 to 2013-06-30779,698USD91
2013-01-01 to 2013-06-301,708,531USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-06-308,546,641USD
At 2013-12-316,384,273USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-06-302,498,345USD
At 2013-12-311,452,324USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-06-30989,114USD
At 2013-12-31427,474USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-06-30265,283USD
At 2013-12-31267,024USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-06-302,276,121USD
At 2013-12-311,982,083USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-04-01 to 2014-06-302,220,503USD91
2014-01-01 to 2014-06-304,297,291USD181
2013-04-01 to 2013-06-301,227,636USD91
2013-01-01 to 2013-06-302,459,959USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-06-301,631,911USD
At 2013-12-311,340,331USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-303,830,624USD91
2014-01-01 to 2014-06-306,731,495USD181
2013-04-01 to 2013-06-302,007,334USD91
2013-01-01 to 2013-06-304,168,490USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-04-01 to 2014-06-30869,745USD91
2014-01-01 to 2014-06-301,526,111USD181
2013-04-01 to 2013-06-30767,719USD91
2013-01-01 to 2013-06-301,234,832USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-04-01 to 2014-06-30225,500USD91
2014-01-01 to 2014-06-30449,804USD181
2013-04-01 to 2013-06-30204,423USD91
2013-01-01 to 2013-06-30364,835USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-06-307,000,000shares
At 2013-12-317,000,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-06-302,678,419USD
At 2013-12-312,346,137USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-06-304,625USD
At 2013-12-31924USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-06-301,276,200USD
At 2013-12-311,057,775USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-06-30765,477USD
At 2013-12-31730,432USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-06-3021,865USD
At 2013-12-318,231USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-06-3058,263USD
At 2013-12-31117,640USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,621,752USD91
2014-01-01 to 2014-06-302,449,287USD181
2013-04-01 to 2013-06-30802,438USD91
2013-01-01 to 2013-06-301,727,931USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,020,347USD91
2014-01-01 to 2014-06-301,545,889USD181
2013-04-01 to 2013-06-30553,989USD91
2013-01-01 to 2013-06-301,198,060USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,130,484USD91
2014-01-01 to 2014-06-302,223,179USD181
2013-04-01 to 2013-06-30527,551USD91
2013-01-01 to 2013-06-301,030,739USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-04-01 to 2014-06-3023,831USD91
2014-01-01 to 2014-06-3035,045USD181
2013-04-01 to 2013-06-3023,828USD91
2013-01-01 to 2013-06-3046,634USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-06-3054,462USD181
2013-01-01 to 2013-06-3065,190USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-04-01 to 2014-06-309,861USD91
2014-01-01 to 2014-06-3019,417USD181
2013-04-01 to 2013-06-309,367USD91
2013-01-01 to 2013-06-3018,556USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-04-01 to 2014-06-3011,631USD91
2014-01-01 to 2014-06-3015,083USD181
2013-04-01 to 2013-06-3022,740USD91
2013-01-01 to 2013-06-3019,400USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30294,038USD181
2013-01-01 to 2013-06-3097,835USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30321,249USD181
2013-01-01 to 2013-06-30103,925USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30239,794USD181
2013-01-01 to 2013-06-30-119,443USD181

Inspect the source

Entity
IRADIMED CORPORATION / CIK 0001325618
Captured
2026-09-20T07:52:33.517Z
SEC response SHA-256
1217db54631fdc625eb836a9c89fbf1ed157044af9ce59b6e200421c6d8ca994

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001325618.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))